REGENXBIO, Inc. (RGNX)
13.08
+0.02
(+0.15%)
USD |
NASDAQ |
Dec 11, 12:18
REGENXBIO EPS Diluted (Quarterly): -1.198 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.94M |
| Revenue (Quarterly) | 29.73M |
| Total Expenses (Quarterly) | 91.67M |
| Enterprise Value | 655.07M |
| Gross Profit Margin (Quarterly) | 67.68% |
| Profit Margin (Quarterly) | -208.3% |
| Earnings Yield | -26.68% |
| Normalized Earnings Yield | -26.68 |